“…[2,3] Although, PG remains excellent in the treatment of DM-2, its use has certain disadvantages: weight gain, obesity, fluid retention, anemia, peripheral edema, congestive heart failure, cholestatic hepatitis and an increase in fracture risk. [4][5][6] Numerous instrumental techniques have been described to quantify PG-HCl in medicinal and biological samples including batch and/or flow injection (FI) based ultraviolet-visible (UV-vis) spectrophotometry, [7][8][9][10][11] spectrofluorometry, [12,13] voltammetry, [14,15] potentiometry, [16,17] capillary electrophoresis (CE), [18] micellar electrokinetic chromatography (MEKC), [19] high-performance liquid chromatography with ultraviolet detectors (HPLC-UV), [19][20][21][22][23] liquid chromatography-tandem mass spectrometry (LC-MS/MS), [24,25] highperformance thin-layer chromatography (HPTLC), [26] reversed phase-TLC [27] and surface enhanced Raman scattering (SERS) spectrometry. [28] A few of these instrumental methods have good sensitivity and precision, but they require time consuming procedures, large volumes of solvents, complex instrumentation, multiple sample preparation steps and longer analysis times.…”